Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless phase II/III design. [electronic resource]
Producer: 20120223Description: 398-407 p. digitalISSN:- 1740-7753
- Acute Disease
- Clinical Trials, Phase II as Topic -- methods
- Clinical Trials, Phase III as Topic -- methods
- Computer Simulation
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Approval
- Early Termination of Clinical Trials
- Fibrinolytic Agents -- administration & dosage
- Humans
- Multicenter Studies as Topic -- methods
- Patient Selection
- Randomized Controlled Trials as Topic -- methods
- Research Design
- Selection Bias
- Stroke -- drug therapy
- Tenecteplase
- Tissue Plasminogen Activator -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.